Arrow Alexander K.

Chief Financial OfficerProtagenic Therapeutics, Inc. ew (PTIXW) · full profile →Form 4 · filed May 20, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 18, 2021Buy(P)18K$0.31$6K30K
May 18, 2021Buy(P)12K$0.32$4K12K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-012357) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about PTIXW insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001493152-21-012357"
Ask your agent
Use Arkolith to summarize insider buying and selling at Protagenic Therapeutics, Inc. ew
over the last 90 days and cite the filings.